Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
- PMID: 10793231
- DOI: 10.1016/s0304-3940(00)01049-1
Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
Abstract
Synucleins are neuronal proteins detectable in the neuropathological lesions of several cerebral disorders. Thus, alpha-synuclein immunoreactivity is found in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease-affected brains. When mutated, alpha-synuclein seems to be responsible for some familial forms of Parkinson disease. As Lewy bodies are enriched in ubiquitinated structures and also contain proteasome-related immunoreactivity, it could be hypothesized that the proteasome contributes to the cellular degradation of alpha-synucleins, thereby controlling their concentration-dependent aggregation process. Here, we first demonstrate that alpha-synuclein is not ubiquitinated in HEK293 cells. Furthermore, by means of two specific inhibitors, we show that wild type and Ala53Thr alpha-synuclein do not behave as proteasome substrates in HEK293 cells and murine neurons. Our study indicates that the proteasome does not contribute to the control of cellular synucleins concentration and therefore, unlikely participates to cerebral alpha-synucleinopathies.
Similar articles
-
Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.Neuroscience. 2001;104(3):901-12. doi: 10.1016/s0306-4522(01)00113-0. Neuroscience. 2001. PMID: 11440819
-
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.FEBS Lett. 2001 Nov 30;509(1):22-6. doi: 10.1016/s0014-5793(01)03115-5. FEBS Lett. 2001. PMID: 11734199
-
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.Neuron. 2002 Dec 19;36(6):1007-19. doi: 10.1016/s0896-6273(02)01125-x. Neuron. 2002. PMID: 12495618
-
[Parkinson's disease: what have we learned from the genes responsible for familial forms?].Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
-
Alpha synuclein in neurodegenerative disorders: murderer or accomplice?Nat Med. 1998 Jul;4(7):755-7. doi: 10.1038/nm0798-755. Nat Med. 1998. PMID: 9662355 Review. No abstract available.
Cited by
-
Protein degradation pathways in Parkinson's disease: curse or blessing.Acta Neuropathol. 2012 Aug;124(2):153-72. doi: 10.1007/s00401-012-1004-6. Epub 2012 Jun 29. Acta Neuropathol. 2012. PMID: 22744791 Free PMC article. Review.
-
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5500-5. doi: 10.1073/pnas.0401081101. Epub 2004 Apr 2. Proc Natl Acad Sci U S A. 2004. PMID: 15064394 Free PMC article.
-
Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.Am J Pathol. 2003 Jul;163(1):91-100. doi: 10.1016/s0002-9440(10)63633-4. Am J Pathol. 2003. PMID: 12819014 Free PMC article.
-
Linkage between the proteasome pathway and neurodegenerative diseases and aging.Mol Neurobiol. 2004 Oct;30(2):201-21. doi: 10.1385/MN:30:2:201. Mol Neurobiol. 2004. PMID: 15475627 Review.
-
Studying protein degradation pathways in vivo using a cranial window-based approach.Methods. 2011 Mar;53(3):194-200. doi: 10.1016/j.ymeth.2010.12.032. Epub 2010 Dec 25. Methods. 2011. PMID: 21187150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
